Reuters logo
5 months ago
BRIEF-Opko Health says plans to initiate a clinical trial of CUR-1916
March 8, 2017 / 2:10 PM / 5 months ago

BRIEF-Opko Health says plans to initiate a clinical trial of CUR-1916

March 8 (Reuters) - Opko Health Inc

* Opko receives EU orphan drug status for its new oligonucleotide to treat genetic neurological disorder

* Opko Health Inc - Opko plans to initiate a clinical trial of CUR-1916 for treatment of dravet syndrome this year Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below